Listen "Cliff Stocks: Founder and CEO of OncoResponse"
Episode Synopsis
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
More episodes of the podcast BioBoss
Welcome to Season 8 of BioBoss
20/12/2025
Michael Cloonan: CEO of Sionna Therapeutics
22/11/2025
Erik van den Berg: CEO of Memo Therapeutics
27/10/2025
Todd Harris: CEO of Tyra Biosciences
30/08/2025
Eduardo Bravo: CEO of Citryll
26/07/2025
Abbas Kazimi: CEO of Nimbus Therapeutics
28/06/2025
Derek Adams: CEO of Stellular Bio
24/05/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.